133 related articles for article (PubMed ID: 11558874)
21. Unilesional mycosis fungoides: a study of seven cases.
Hodak E; Phenig E; Amichai B; Feinmesser M; Kuten A; Maron L; Sahar D; Bergman R; David M
Dermatology; 2000; 201(4):300-6. PubMed ID: 11146338
[TBL] [Abstract][Full Text] [Related]
22. Adult pityriasis lichenoides-like mycosis fungoides: a clinical variant of mycosis fungoides.
de Unamuno Bustos B; Ferriols AP; Sánchez RB; Rabasco AG; Vela CG; Piris MA; Alegre de Míquel V
Int J Dermatol; 2014 Nov; 53(11):1331-8. PubMed ID: 24961281
[TBL] [Abstract][Full Text] [Related]
23. Unilesional plantar mycosis fungoides treated with topical photodynamic therapy - case report and review of the literature.
Kaufmann F; Kettelhack N; Hilty N; Kempf W
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1633-1637. PubMed ID: 28168737
[TBL] [Abstract][Full Text] [Related]
24. Topical methyl aminolaevulinate-photodynamic therapy in erosive facial mycosis fungoides.
Debu A; Girard C; Kluger N; Guillot B; Dereure O
Br J Dermatol; 2010 Oct; 163(4):884-5. PubMed ID: 20854405
[No Abstract] [Full Text] [Related]
25. Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.
Kim EJ; Mangold AR; DeSimone JA; Wong HK; Seminario-Vidal L; Guitart J; Appel J; Geskin L; Lain E; Korman NJ; Zeitouni N; Nikbakht N; Dawes K; Akilov O; Carter J; Shinohara M; Kuzel TM; Piette W; Bhatia N; Musiek A; Pariser D; Kim YH; Elston D; Boh E; Duvic M; Huen A; Pacheco T; Zwerner JP; Lee ST; Girardi M; Querfeld C; Bohjanen K; Olsen E; Wood GS; Rumage A; Donini O; Haulenbeek A; Schaber CJ; Straube R; Pullion C; Rook AH; Poligone B
JAMA Dermatol; 2022 Sep; 158(9):1031-1039. PubMed ID: 35857290
[TBL] [Abstract][Full Text] [Related]
26. Transformation of mycosis fungoides: T-cell receptor beta gene analysis demonstrates a common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma.
Wood GS; Bahler DW; Hoppe RT; Warnke RA; Sklar JL; Levy R
J Invest Dermatol; 1993 Sep; 101(3):296-300. PubMed ID: 8396607
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy of residual or recurrent basal cell carcinoma after radiotherapy using topical 5-aminolevulinic acid or methylester aminolevulinic acid.
Soler AM; Warloe T; Tausjø J; Giercksky KE
Acta Oncol; 2000; 39(5):605-9. PubMed ID: 11093368
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy and plaque phase mycosis fungoides.
Fernández-Guarino M; Jaén P
G Ital Dermatol Venereol; 2011 Dec; 146(6):457-61. PubMed ID: 22095177
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
Boiy A; Roelandts R; de Witte PA
J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion.
Hürlimann AF; Hänggi G; Panizzon RG
Dermatology; 1998; 197(3):248-54. PubMed ID: 9812030
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic therapy with methyl aminolaevulinate for cervical and/or facial lesions of folliculotropic mycosis fungoides: interest and limits.
Debu A; Bessis D; Girard C; Du Thanh A; Guillot B; Dereure O
Br J Dermatol; 2013 Apr; 168(4):896-8. PubMed ID: 23013351
[No Abstract] [Full Text] [Related]
32. Photodynamic therapy as an alternative treatment for relapsed or refractory mycosis fungoides: A systemic review.
Xue J; Liu C; Liu Y
Photodiagnosis Photodyn Ther; 2017 Mar; 17():87-91. PubMed ID: 27888162
[TBL] [Abstract][Full Text] [Related]
33. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study.
Apisarnthanarax N; Talpur R; Ward S; Ni X; Kim HW; Duvic M
J Am Acad Dermatol; 2004 Apr; 50(4):600-7. PubMed ID: 15034511
[TBL] [Abstract][Full Text] [Related]
34. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma.
Rhodes LE; de Rie MA; Leifsdottir R; Yu RC; Bachmann I; Goulden V; Wong GA; Richard MA; Anstey A; Wolf P
Arch Dermatol; 2007 Sep; 143(9):1131-6. PubMed ID: 17875873
[TBL] [Abstract][Full Text] [Related]
35. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma.
Vinciullo C; Elliott T; Francis D; Gebauer K; Spelman L; Nguyen R; Weightman W; Sheridan A; Reid C; Czarnecki D; Murrell D
Br J Dermatol; 2005 Apr; 152(4):765-72. PubMed ID: 15840111
[TBL] [Abstract][Full Text] [Related]
36. Photochemotherapy for mycosis fungoides: a clinical and histological study.
Lowe NJ; Cripps DJ; Dufton PA; Vickers CF
Arch Dermatol; 1979 Jan; 115(1):50-3. PubMed ID: 760657
[TBL] [Abstract][Full Text] [Related]
37. High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study.
Christensen E; Mørk C; Skogvoll E
Br J Dermatol; 2012 Jun; 166(6):1342-8. PubMed ID: 22309486
[TBL] [Abstract][Full Text] [Related]
38. Mycosis fungoides: an updated review of clinicopathologic variants.
Ahn CS; ALSayyah A; Sangüeza OP
Am J Dermatopathol; 2014 Dec; 36(12):933-48; quiz 949-51. PubMed ID: 25415138
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of photodynamic therapy in the treatment of lichen sclerosus: cell changes in immunohistochemistry.
Olejek A; Kozak-Darmas I; Kellas-Sleczka S; Steplewska K; Biniszkiewicz T; Birkner B; Jarek A; Nowak L; Stencel-Gabriel K; Sieron A
Neuro Endocrinol Lett; 2009; 30(4):547-51. PubMed ID: 20010496
[TBL] [Abstract][Full Text] [Related]
40. Terapêutica Fotodinâmica com metil-aminolevulinato no tratamento de lesões refractárias de Micose Fungóide: resposta clínica e histológica mantida em dois doentes.
Teixeira AI; Maia E Silva J
Dermatol Online J; 2016 Sep; 22(9):. PubMed ID: 28329611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
